Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jolles

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Immunology|August 29, 2002
High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disordersS Jolles
Clinical and Experimental Dermatology|April 12, 2001
A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disordersS Jolles
Clinical and Experimental Dermatology|April 16, 2002
A review of high-dose intravenous immunoglobulin treatment for atopic dermatitisS Jolles
Journal of Clinical Pathology|March 29, 2002
Paul LangerhansS Jolles
Clinical and Experimental Immunology|December 30, 2014
Subclinical infection and dosing in primary immunodeficienciesS Jolles
Clinical and Experimental Dermatology|June 15, 2005
The role of complement testing in dermatologyS Jamal, S Jolles
Africa : Journal of the International Institute of African Languages and Cultures|March 26, 2008
Zulu ritual immunisation in perspectiveF Jolles, S Jolles
The British Journal of Dermatology|June 28, 2003
Importance of trial design in studies using high-dose intravenous immunoglobulinS Jolles, J Hughes
Lancet (London, England)|November 4, 1998
African traditional medicine--potential route for viral transmission?S Jolles, F Jolles
BMJ (Clinical Research Ed.)|April 29, 1998
Management of aseptic meningitis secondary to intravenous immunoglobulinS Jolles, H Hill
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Immunology|August 29, 2002
High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disordersS Jolles
Clinical and Experimental Dermatology|April 12, 2001
A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disordersS Jolles
Clinical and Experimental Dermatology|April 16, 2002
A review of high-dose intravenous immunoglobulin treatment for atopic dermatitisS Jolles
Journal of Clinical Pathology|March 29, 2002
Paul LangerhansS Jolles
Clinical and Experimental Immunology|December 30, 2014
Subclinical infection and dosing in primary immunodeficienciesS Jolles
Clinical and Experimental Dermatology|June 15, 2005
The role of complement testing in dermatologyS Jamal, S Jolles
Africa : Journal of the International Institute of African Languages and Cultures|March 26, 2008
Zulu ritual immunisation in perspectiveF Jolles, S Jolles
The British Journal of Dermatology|June 28, 2003
Importance of trial design in studies using high-dose intravenous immunoglobulinS Jolles, J Hughes
Lancet (London, England)|November 4, 1998
African traditional medicine--potential route for viral transmission?S Jolles, F Jolles
BMJ (Clinical Research Ed.)|April 29, 1998
Management of aseptic meningitis secondary to intravenous immunoglobulinS Jolles, H Hill
Pageof 7